Zacks: Analysts Anticipate Danaher Co. (NYSE:DHR) Will Post Earnings of $1.15 Per Share

Wall Street analysts expect Danaher Co. (NYSE:DHR) to report earnings of $1.15 per share for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Danaher’s earnings, with the highest EPS estimate coming in at $1.16 and the lowest estimate coming in at $1.14. Danaher reported earnings of $1.10 per share in the same quarter last year, which indicates a positive year over year growth rate of 4.5%. The business is expected to report its next quarterly earnings results on Thursday, October 17th.

On average, analysts expect that Danaher will report full year earnings of $4.79 per share for the current fiscal year, with EPS estimates ranging from $4.77 to $4.81. For the next fiscal year, analysts forecast that the company will report earnings of $5.70 per share, with EPS estimates ranging from $5.55 to $5.80. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that follow Danaher.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.04. The company had revenue of $5.16 billion for the quarter, compared to analysts’ expectations of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period last year, the firm posted $1.15 earnings per share.

A number of brokerages have recently weighed in on DHR. Argus lifted their price target on shares of Danaher to $165.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. ValuEngine cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday. Piper Jaffray Companies lifted their price target on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a research report on Thursday, July 18th. Royal Bank of Canada set a $134.00 price target on shares of Danaher and gave the stock a “hold” rating in a research report on Friday, July 19th. Finally, Wolfe Research set a $157.00 price target on shares of Danaher and gave the stock a “buy” rating in a research report on Thursday, September 26th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Danaher presently has an average rating of “Buy” and a consensus price target of $144.50.

In related news, insider Brian W. Ellis sold 1,010 shares of the firm’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $144.04, for a total transaction of $145,480.40. Following the sale, the insider now directly owns 20,889 shares in the company, valued at $3,008,851.56. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Chairman Mitchell P. Rales acquired 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were bought at an average price of $139.52 per share, for a total transaction of $348,800.00. Following the completion of the acquisition, the chairman now owns 3,030,453 shares of the company’s stock, valued at $422,808,802.56. The disclosure for this purchase can be found here. Over the last 90 days, insiders have sold 177,202 shares of company stock worth $25,175,829. 11.40% of the stock is currently owned by company insiders.

Several large investors have recently modified their holdings of the stock. Next Capital Management LLC acquired a new stake in Danaher in the 2nd quarter valued at $31,000. Litman Gregory Asset Management LLC acquired a new stake in Danaher in the 2nd quarter valued at $33,000. Altshuler Shaham Ltd increased its stake in Danaher by 59.3% in the 2nd quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock valued at $34,000 after buying an additional 89 shares during the last quarter. MRA Associates USA LLC acquired a new stake in Danaher in the 2nd quarter valued at $40,000. Finally, Capital Advisors Ltd. LLC increased its stake in Danaher by 527.5% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 320 shares of the conglomerate’s stock valued at $46,000 after buying an additional 269 shares during the last quarter. Institutional investors and hedge funds own 78.43% of the company’s stock.

Shares of NYSE DHR traded up $2.84 during midday trading on Monday, reaching $141.65. 1,872,916 shares of the stock were exchanged, compared to its average volume of 2,535,280. The business has a 50-day simple moving average of $141.15 and a two-hundred day simple moving average of $137.02. The company has a market capitalization of $101.62 billion, a price-to-earnings ratio of 31.34, a P/E/G ratio of 2.37 and a beta of 0.94. Danaher has a 12 month low of $94.59 and a 12 month high of $147.33. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.32 and a quick ratio of 1.91.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be issued a dividend of $0.17 per share. The ex-dividend date is Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.48%. Danaher’s payout ratio is 15.04%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: Calculate Your Return on Investment (ROI)

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.